NCT00797316 Aliskiren Plus HCTZ Compared to Aliskiren in Metabolic Syndrome Patients With Stage 2 Systolic Hypertension Status COMPLETED Phase PHASE4
NCT00795418 Safety and Tolerability of Repeated Subcutaneous Injections of CAD 106 in Mild Alzheimer's Patients Status COMPLETED Phase PHASE2
NCT00792766 Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM) Status COMPLETED Phase PHASE1/PHASE2
NCT00789841 Gastrointestinal Motility in Patients With Neuroendocrine Tumors Status COMPLETED Phase N/A
NCT00788775 Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma Status COMPLETED Phase PHASE2
NCT00788060 A Phase Ib Study of Rad001 and Sutent to Treat Renal Cell Carcinoma Status COMPLETED Phase PHASE1
NCT00787605 Aliskiren HCTZ Compared to Amlodipine in Patients With Stage 2 Systolic Hypertension and Diabetes Mellitus Status COMPLETED Phase PHASE4
NCT00785083 A Study of the Effect of FTY720 on Pulmonary Function in Patients With Moderate Asthma Status COMPLETED Phase PHASE2
NCT00784732 A Study to Compare the Efficacy of QAV680 Against Placebo in Treating Seasonal Allergic Rhinitis in an Environmental Exposure Chamber Status COMPLETED Phase PHASE2
NCT00782626 Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas Status COMPLETED Phase PHASE2
NCT00778921 Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients With Hypertension Not Adequately Responding to Amlodipine Alone Status COMPLETED Phase PHASE3
NCT00777946 Study to Evaluate the Efficacy and Safety of Combination Aliskiren/Amlodipine in Patients Not Adequately Responding to Aliskiren Alone Status COMPLETED Phase PHASE3
NCT00772577 Study of the Efficacy and Safety of Aliskiren HCTZ vs Ramipril in Obese Patients (BMI ≥ 30) With Stage 2 Hypertension Status COMPLETED Phase PHASE4
NCT00772161 Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD) Status COMPLETED Phase PHASE1/PHASE2
NCT00770081 Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study) Status COMPLETED Phase PHASE3
NCT00765947 Efficacy and Tolerability of an Aliskiren-based Treatment Algorithm in Patients With Mild to Moderate Hypertension Status COMPLETED Phase PHASE4
NCT00765830 Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension) Status COMPLETED Phase PHASE3